Jamie E. Anderson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jamie E. Anderson has a total of 96 co-authors. Here are the top co-authors by number of shared publications:
- Xiang Zeng
The Second Clinical School of Guangzhou University of Chinese Medicine/The Second Affiliated Hospital of Guangzhou University of Chinese Medicine/Guangdong Provincial Hospital of Chinese Medicine/Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou, China
8 shared publications - Yang D. Teng
Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, MA 02129, USA
8 shared publications Alexander E. Ropper
Division of SCI Research, Veterans Affairs Boston Healthcare System, Boston, MA 02130
4 shared publicationsDou Yu
Division of SCI Research, Veterans Affairs Boston Healthcare System, Boston, MA 02130
4 shared publications- John Peter Campbell
Casey Eye Institute, Oregon Health and Science University, Portland, OR, USA
4 shared publications Aaron S. Coyner
Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Oregon
3 shared publications
Latest Publications
- 2 November 2026
- Published by Wiley in Optometry and Vision Science
- Vol. 103 (11)
Trends in real‐world atropine prescribing for myopia control across evidence eras
Purpose: Identify trends in atropine prescribing and concentration adjustments for pediatric myopia control across multiple U.S. academic eye centers. Methods: A multicenter, retrospective chart review was conducted of children (ages 3–17 years) prescribed low‐concentration atropine for myopia management at three academic medical centers in the United States: the Casey Eye Institute, Oregon Health & Science University, the Ann & Robert H. Lurie Children's Hospital of Chicago, and the Rady Children's Hospital Orange County. Descriptive statistics were used to characterize the data and summarize prescribing patterns, concentration changes, and follow‐up rates by enrollment period and initial atropine concentration. Results: A total of 435 patients were identified across all study sites. In the Early Low‐Dose Atropine Era, 0.01% atropine was the only starting concentration prescribed. Prescribing subsequently shifted toward higher concentrations. Prescribing of 0.05% atropine increased substantially, accounting for 45.7% of baseline prescriptions. Across subsequent evidence eras, changes in concentration increased in frequency, with greater concentration escalation over time, and these increases were most frequent during the Post‐LAMP Era (24.4%). Conclusions: A clear shift in atropine prescribing patterns for pediatric myopia management was identified over the course of the study period. During the Early Low‐Dose Atropine Era, clinicians exclusively prescribed the lowest concentration of atropine (0.01%), and only a small proportion of patients were escalated to a higher concentration at 12 months. In the Post‐LAMP Era, there was a broader distribution of baseline dosing, with increased use of 0.02%/0.025% and 0.05% atropine and a higher proportion of patients having concentration increases. During the Contemporary Evidence Era, 0.05% became the predominant starting concentration. The shifts in prescribing patterns highlight the dynamic and responsive nature of clinical decision‐making and underscore a growing trend toward comfortability with personalized myopia management in pediatric eye care, suggesting evolving individualized titration strategies and experimental dosage management methods.
- 2 November 2026
- Published by Wiley in Optometry and Vision Science
- Vol. 103 (11)
Trends in real‐world atropine prescribing for myopia control across evidence eras
Purpose: Identify trends in atropine prescribing and concentration adjustments for pediatric myopia control across multiple U.S. academic eye centers. Methods: A multicenter, retrospective chart review was conducted of children (ages 3–17 years) prescribed low‐concentration atropine for myopia management at three academic medical centers in the United States: the Casey Eye Institute, Oregon Health & Science University, the Ann & Robert H. Lurie Children's Hospital of Chicago, and the Rady Children's Hospital Orange County. Descriptive statistics were used to characterize the data and summarize prescribing patterns, concentration changes, and follow‐up rates by enrollment period and initial atropine concentration. Results: A total of 435 patients were identified across all study sites. In the Early Low‐Dose Atropine Era, 0.01% atropine was the only starting concentration prescribed. Prescribing subsequently shifted toward higher concentrations. Prescribing of 0.05% atropine increased substantially, accounting for 45.7% of baseline prescriptions. Across subsequent evidence eras, changes in concentration increased in frequency, with greater concentration escalation over time, and these increases were most frequent during the Post‐LAMP Era (24.4%). Conclusions: A clear shift in atropine prescribing patterns for pediatric myopia management was identified over the course of the study period. During the Early Low‐Dose Atropine Era, clinicians exclusively prescribed the lowest concentration of atropine (0.01%), and only a small proportion of patients were escalated to a higher concentration at 12 months. In the Post‐LAMP Era, there was a broader distribution of baseline dosing, with increased use of 0.02%/0.025% and 0.05% atropine and a higher proportion of patients having concentration increases. During the Contemporary Evidence Era, 0.05% became the predominant starting concentration. The shifts in prescribing patterns highlight the dynamic and responsive nature of clinical decision‐making and underscore a growing trend toward comfortability with personalized myopia management in pediatric eye care, suggesting evolving individualized titration strategies and experimental dosage management methods.
- Open Access
- 1 March 2025
- Published by KEAI Publishing in Global Health Journal
- Vol. 9 (1) , 27-36
Knowledge acquisition and retention when implementing public health awareness training on common pediatric eye conditions in Thailand
Low awareness of common pediatric eye conditions, such as amblyopia, conjunctivitis, and myopia in rural Chiang Rai, Thailand, prompted the development of a specialized curriculum. This curriculum aimed to provide individuals serving these areas with resources to educate and disseminate information within their communities. A one-hour curriculum covering the causes, signs, diagnosis, treatment, and prevention of amblyopia, conjunctivitis, and myopia was delivered virtually to public health students at a Thai university and in-person to students at this university and rural community members. The in-person seminar included hands-on activities and simulations of these eye conditions. Knowledge acquisition and retention were assessed using pre-tests, immediate post-tests, and one-month post-tests. The seminar was attended by 87 virtual public health students, 111 in-person public health students, and 40 in-person rural community members. All groups showed significant improvement in test scores from pre-test to immediate post-test (P < 0.001). In-person students had 1.57 times the odds of answering correctly on the immediate post-test compared to virtual students, despite no significant difference in baseline knowledge. However, the subset of in-person students who did not receive bilingual materials showed no significant difference in immediate post-test performance compared to virtual students (P > 0.05). Although public health students had more than twice the odds of answering correctly at pre-test compared to rural community members, there were no significant differences between groups on the immediate post-test (P > 0.05). A brief seminar significantly improved understanding and retention of pediatric eye conditions, achieving similar levels of understanding among public health students and rural community members, regardless of initial knowledge on this topic. In-person, hands-on seminars with educational materials in participants’ preferred language proved more effective than virtual ones in achieving these improvements.
- 1 March 2025
- Published by KEAI Publishing in Global Health Journal
- Vol. 9 (1) , 27-36
Open AccessKnowledge acquisition and retention when implementing public health awareness training on common pediatric eye conditions in Thailand
Low awareness of common pediatric eye conditions, such as amblyopia, conjunctivitis, and myopia in rural Chiang Rai, Thailand, prompted the development of a specialized curriculum. This curriculum aimed to provide individuals serving these areas with resources to educate and disseminate information within their communities. A one-hour curriculum covering the causes, signs, diagnosis, treatment, and prevention of amblyopia, conjunctivitis, and myopia was delivered virtually to public health students at a Thai university and in-person to students at this university and rural community members. The in-person seminar included hands-on activities and simulations of these eye conditions. Knowledge acquisition and retention were assessed using pre-tests, immediate post-tests, and one-month post-tests. The seminar was attended by 87 virtual public health students, 111 in-person public health students, and 40 in-person rural community members. All groups showed significant improvement in test scores from pre-test to immediate post-test (P < 0.001). In-person students had 1.57 times the odds of answering correctly on the immediate post-test compared to virtual students, despite no significant difference in baseline knowledge. However, the subset of in-person students who did not receive bilingual materials showed no significant difference in immediate post-test performance compared to virtual students (P > 0.05). Although public health students had more than twice the odds of answering correctly at pre-test compared to rural community members, there were no significant differences between groups on the immediate post-test (P > 0.05). A brief seminar significantly improved understanding and retention of pediatric eye conditions, achieving similar levels of understanding among public health students and rural community members, regardless of initial knowledge on this topic. In-person, hands-on seminars with educational materials in participants’ preferred language proved more effective than virtual ones in achieving these improvements.
- Open Access
Concurrent Oncolysis and Neurolesion Repair by Dual Gene-Engineered hNSCs in an Experimental Model of Intraspinal Cord Glioblastoma
Intramedullary spinal cord glioblastoma (ISCG) is lethal due to lack of effective treatment. We previously established a rat C6-ISCG model and the antitumor effect of F3.CD-TK, an hNSC line expressing CD and TK, via producing cytocidal 5FU and GCV-TP. However, the neurotherapeutic potential of this hNSC approach has remained uninvestigated. Here for the first time, cultured F3.CD-TK cells were found to have a markedly higher oncolytic effect, which was GJIC-dependent, and BDNF expression but less VEGF secretion than F3.CD. In Rowett athymic rats, F3.CD-TK (1.5 × 106 cells/10 µL × 2), injected near C6-ISCG (G55 seeding 7 days earlier: 10 K/each) and followed by q.d. (×5/each repeat; i.p.) of 5FC (500 mg/kg/5 mL/day) and GCV (25 mg/kg/1 mL/day), robustly mitigated cardiorespiratory, locomotor, and sensory deficits to improve neurofunction and overall survival compared to animals receiving either F3.CD or F3.CD-TK+F3.CD debris formula. The F3.CD-TK regimen exerted greater tumor penetration and neural inflammation/immune modulation, reshaped C6-ISCG topology to increase the tumor’s surface area/volume ratio to spare/repair host axons (e.g., vGlut1+ neurites), and had higher post-prodrug donor self-clearance. The multimodal data and mechanistic leads from this proof-of-principle study suggest that the overall stronger anti-ISCG benefit of our hNSC-based GDEPT is derived from its concurrent oncolytic and neurotherapeutic effects.
Open AccessConcurrent Oncolysis and Neurolesion Repair by Dual Gene-Engineered hNSCs in an Experimental Model of Intraspinal Cord Glioblastoma
Intramedullary spinal cord glioblastoma (ISCG) is lethal due to lack of effective treatment. We previously established a rat C6-ISCG model and the antitumor effect of F3.CD-TK, an hNSC line expressing CD and TK, via producing cytocidal 5FU and GCV-TP. However, the neurotherapeutic potential of this hNSC approach has remained uninvestigated. Here for the first time, cultured F3.CD-TK cells were found to have a markedly higher oncolytic effect, which was GJIC-dependent, and BDNF expression but less VEGF secretion than F3.CD. In Rowett athymic rats, F3.CD-TK (1.5 × 106 cells/10 µL × 2), injected near C6-ISCG (G55 seeding 7 days earlier: 10 K/each) and followed by q.d. (×5/each repeat; i.p.) of 5FC (500 mg/kg/5 mL/day) and GCV (25 mg/kg/1 mL/day), robustly mitigated cardiorespiratory, locomotor, and sensory deficits to improve neurofunction and overall survival compared to animals receiving either F3.CD or F3.CD-TK+F3.CD debris formula. The F3.CD-TK regimen exerted greater tumor penetration and neural inflammation/immune modulation, reshaped C6-ISCG topology to increase the tumor’s surface area/volume ratio to spare/repair host axons (e.g., vGlut1+ neurites), and had higher post-prodrug donor self-clearance. The multimodal data and mechanistic leads from this proof-of-principle study suggest that the overall stronger anti-ISCG benefit of our hNSC-based GDEPT is derived from its concurrent oncolytic and neurotherapeutic effects.
- Open Access
T12-L3 Nerve Transfer-Induced Locomotor Recovery in Rats with Thoracolumbar Contusion: Essential Roles of Sensory Input Rerouting and Central Neuroplasticity
Locomotor recovery after spinal cord injury (SCI) remains an unmet challenge. Nerve transfer (NT), the connection of a functional/expendable peripheral nerve to a paralyzed nerve root, has long been clinically applied, aiming to restore motor control. However, outcomes have been inconsistent, suggesting that NT-induced neurological reinstatement may require activation of mechanisms beyond motor axon reinnervation (our hypothesis). We previously reported that to enhance rat locomotion following T13-L1 hemisection, T12-L3 NT must be performed within timeframes optimal for sensory nerve regrowth. Here, T12-L3 NT was performed for adult female rats with subacute (7–9 days) or chronic (8 weeks) mild (SCImi: 10 g × 12.5 mm) or moderate (SCImo: 10 g × 25 mm) T13-L1 thoracolumbar contusion. For chronic injuries, T11-12 implantation of adult hMSCs (1-week before NT), post-NT intramuscular delivery of FGF2, and environmentally enriched/enlarged (EEE) housing were provided. NT, not control procedures, qualitatively improved locomotion in both SCImi groups and animals with subacute SCImo. However, delayed NT did not produce neurological scale upgrading conversion for SCImo rats. Ablation of the T12 ventral/motor or dorsal/sensory root determined that the T12-L3 sensory input played a key role in hindlimb reanimation. Pharmacological, electrophysiological, and trans-synaptic tracing assays revealed that NT strengthened integrity of the propriospinal network, serotonergic neuromodulation, and the neuromuscular junction. Besides key outcomes of thoracolumbar contusion modeling, the data provides the first evidence that mixed NT-induced locomotor efficacy may rely pivotally on sensory rerouting and pro-repair neuroplasticity to reactivate neurocircuits/central pattern generators. The finding describes a novel neurobiology mechanism underlying NT, which can be targeted for development of innovative neurotization therapies.
Open AccessT12-L3 Nerve Transfer-Induced Locomotor Recovery in Rats with Thoracolumbar Contusion: Essential Roles of Sensory Input Rerouting and Central Neuroplasticity
Locomotor recovery after spinal cord injury (SCI) remains an unmet challenge. Nerve transfer (NT), the connection of a functional/expendable peripheral nerve to a paralyzed nerve root, has long been clinically applied, aiming to restore motor control. However, outcomes have been inconsistent, suggesting that NT-induced neurological reinstatement may require activation of mechanisms beyond motor axon reinnervation (our hypothesis). We previously reported that to enhance rat locomotion following T13-L1 hemisection, T12-L3 NT must be performed within timeframes optimal for sensory nerve regrowth. Here, T12-L3 NT was performed for adult female rats with subacute (7–9 days) or chronic (8 weeks) mild (SCImi: 10 g × 12.5 mm) or moderate (SCImo: 10 g × 25 mm) T13-L1 thoracolumbar contusion. For chronic injuries, T11-12 implantation of adult hMSCs (1-week before NT), post-NT intramuscular delivery of FGF2, and environmentally enriched/enlarged (EEE) housing were provided. NT, not control procedures, qualitatively improved locomotion in both SCImi groups and animals with subacute SCImo. However, delayed NT did not produce neurological scale upgrading conversion for SCImo rats. Ablation of the T12 ventral/motor or dorsal/sensory root determined that the T12-L3 sensory input played a key role in hindlimb reanimation. Pharmacological, electrophysiological, and trans-synaptic tracing assays revealed that NT strengthened integrity of the propriospinal network, serotonergic neuromodulation, and the neuromuscular junction. Besides key outcomes of thoracolumbar contusion modeling, the data provides the first evidence that mixed NT-induced locomotor efficacy may rely pivotally on sensory rerouting and pro-repair neuroplasticity to reactivate neurocircuits/central pattern generators. The finding describes a novel neurobiology mechanism underlying NT, which can be targeted for development of innovative neurotization therapies.
- 12 October 2023
- Published by Elsevier in Ophthalmology Retina
- Vol. 8 (2) , 202-204
Macular Thickness Is Associated with Persistent Avascular Retina in Patients with a History of Untreated Retinopathy of Prematurity
- 12 October 2023
- Published by Elsevier in Ophthalmology Retina
- Vol. 8 (2) , 202-204
Macular Thickness Is Associated with Persistent Avascular Retina in Patients with a History of Untreated Retinopathy of Prematurity
- Open Access
- 1 February 2022
- Published by Elsevier in Journal of American Association for Pediatric Ophthalmology and Strabismus
- Vol. 26 (1) , 29-31
Prevalence of persistent avascular retina in untreated children with a history of retinopathy of prematurity screening
- 1 February 2022
- Published by Elsevier in Journal of American Association for Pediatric Ophthalmology and Strabismus
- Vol. 26 (1) , 29-31
Open AccessPrevalence of persistent avascular retina in untreated children with a history of retinopathy of prematurity screening
- Open Access
- 1 December 2021
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 148 (6)
Single-Examination Risk Prediction of Severe Retinopathy of Prematurity
Video Abstract Video Abstract Retinopathy of prematurity (ROP) is a leading cause of childhood blindness. Screening and treatment reduces this risk, but requires multiple examinations of infants, most of whom will not develop severe disease. Previous work has suggested that artificial intelligence may be able to detect incident severe disease (treatment-requiring retinopathy of prematurity [TR-ROP]) before clinical diagnosis. We aimed to build a risk model that combined artificial intelligence with clinical demographics to reduce the number of examinations without missing cases of TR-ROP. Infants undergoing routine ROP screening examinations (1579 total eyes, 190 with TR-ROP) were recruited from 8 North American study centers. A vascular severity score (VSS) was derived from retinal fundus images obtained at 32 to 33 weeks’ postmenstrual age. Seven ElasticNet logistic regression models were trained on all combinations of birth weight, gestational age, and VSS. The area under the precision-recall curve was used to identify the highest-performing model. The gestational age + VSS model had the highest performance (mean ± SD area under the precision-recall curve: 0.35 ± 0.11). On 2 different test data sets (n = 444 and n = 132), sensitivity was 100% (positive predictive value: 28.1% and 22.6%) and specificity was 48.9% and 80.8% (negative predictive value: 100.0%). Using a single examination, this model identified all infants who developed TR-ROP, on average, >1 month before diagnosis with moderate to high specificity. This approach could lead to earlier identification of incident severe ROP, reducing late diagnosis and treatment while simultaneously reducing the number of ROP examinations and unnecessary physiologic stress for low-risk infants.
- 1 December 2021
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 148 (6)
Open AccessSingle-Examination Risk Prediction of Severe Retinopathy of Prematurity
Video Abstract Video Abstract Retinopathy of prematurity (ROP) is a leading cause of childhood blindness. Screening and treatment reduces this risk, but requires multiple examinations of infants, most of whom will not develop severe disease. Previous work has suggested that artificial intelligence may be able to detect incident severe disease (treatment-requiring retinopathy of prematurity [TR-ROP]) before clinical diagnosis. We aimed to build a risk model that combined artificial intelligence with clinical demographics to reduce the number of examinations without missing cases of TR-ROP. Infants undergoing routine ROP screening examinations (1579 total eyes, 190 with TR-ROP) were recruited from 8 North American study centers. A vascular severity score (VSS) was derived from retinal fundus images obtained at 32 to 33 weeks’ postmenstrual age. Seven ElasticNet logistic regression models were trained on all combinations of birth weight, gestational age, and VSS. The area under the precision-recall curve was used to identify the highest-performing model. The gestational age + VSS model had the highest performance (mean ± SD area under the precision-recall curve: 0.35 ± 0.11). On 2 different test data sets (n = 444 and n = 132), sensitivity was 100% (positive predictive value: 28.1% and 22.6%) and specificity was 48.9% and 80.8% (negative predictive value: 100.0%). Using a single examination, this model identified all infants who developed TR-ROP, on average, >1 month before diagnosis with moderate to high specificity. This approach could lead to earlier identification of incident severe ROP, reducing late diagnosis and treatment while simultaneously reducing the number of ROP examinations and unnecessary physiologic stress for low-risk infants.
- Open Access
- 22 October 2021
- Published by Elsevier in Ophthalmology Science
- Vol. 1 (4) , 100070
Quantification of Early Neonatal Oxygen Exposure as a Risk Factor for Retinopathy of Prematurity Requiring Treatment
- 22 October 2021
- Published by Elsevier in Ophthalmology Science
- Vol. 1 (4) , 100070
Open AccessQuantification of Early Neonatal Oxygen Exposure as a Risk Factor for Retinopathy of Prematurity Requiring Treatment
- 1 January 2018
- Published by AME Publishing Company in Shanghai Chest
- Vol. 2 (4) , 24
Should the surgical decision be influenced by the diagnostic biopsy in mesothelioma?
Surgical resection is offered to some patients with malignant pleural mesothelioma (MPM), depending on fitness for surgery and apparent technical resectability of the tumor. Due to risk of surgery-related morbidity and mortality in patients with a fatal malignancy, life expectancy is also a primary consideration in the surgical decision. Prognosis is related to the stage and histological subtype of the disease, neither of which can be known with certainty prior to definitive pathological review of the tumor specimen. Therefore, radiology and pleural biopsy, respectively, are used to predict these prognostic factors and to determine potential benefit from surgical intervention. In this review, we discuss the current limitations of histologic subtyping using pleural biopsy as a preoperative predictor. In addition, we explore available and emerging non-histologic analyses of biopsy specimens to evaluate molecular biomarkers, predicted neoantigens and the immune microenvironment. In the context of novel biological and immune-based treatment strategies currently under investigation for mesothelioma, accurate prognostic and predictive information available from biopsy material will likely influence treatment strategy including the surgical decision.
- 1 January 2018
- Published by AME Publishing Company in Shanghai Chest
- Vol. 2 (4) , 24
Should the surgical decision be influenced by the diagnostic biopsy in mesothelioma?
Surgical resection is offered to some patients with malignant pleural mesothelioma (MPM), depending on fitness for surgery and apparent technical resectability of the tumor. Due to risk of surgery-related morbidity and mortality in patients with a fatal malignancy, life expectancy is also a primary consideration in the surgical decision. Prognosis is related to the stage and histological subtype of the disease, neither of which can be known with certainty prior to definitive pathological review of the tumor specimen. Therefore, radiology and pleural biopsy, respectively, are used to predict these prognostic factors and to determine potential benefit from surgical intervention. In this review, we discuss the current limitations of histologic subtyping using pleural biopsy as a preoperative predictor. In addition, we explore available and emerging non-histologic analyses of biopsy specimens to evaluate molecular biomarkers, predicted neoantigens and the immune microenvironment. In the context of novel biological and immune-based treatment strategies currently under investigation for mesothelioma, accurate prognostic and predictive information available from biopsy material will likely influence treatment strategy including the surgical decision.
- 17 January 2017
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 114 (5) , E820-E829
Defining recovery neurobiology of injured spinal cord by synthetic matrix-assisted hMSC implantation
Significance: We developed a platform technology to determine therapeutic mechanisms of human mesenchymal stromal stem cells (hMSCs) in a dorsal root ganglion coculture system and an intraspinal cord implantation model. The unique poly(lactic- co- glycolic) acid scaffolding augments hMSC stemness, engraftment, and function without neural transdifferentiation or mesenchymal lineage development, resulting in robust motosensory improvement, pain and tissue damage mitigation, and myelin preservation in adult rat spinal cord after injury. The scaffolded hMSC-derived neurotrophism, neurogenesis, angiogenesis, antiautoimmunity, and antiinflammation support the propriospinal network, neuromuscular junctions, and serotonergic reticulospinal reinnervation to activate the central pattern generator for restoring hindlimb locomotion. Our findings illuminate “recovery neurobiology”—i.e., the injured spinal cord may deploy polysynaptic neural circuits different from normal adulthood pathways for postinjury improvement.
- 17 January 2017
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 114 (5) , E820-E829
Defining recovery neurobiology of injured spinal cord by synthetic matrix-assisted hMSC implantation
Significance: We developed a platform technology to determine therapeutic mechanisms of human mesenchymal stromal stem cells (hMSCs) in a dorsal root ganglion coculture system and an intraspinal cord implantation model. The unique poly(lactic- co- glycolic) acid scaffolding augments hMSC stemness, engraftment, and function without neural transdifferentiation or mesenchymal lineage development, resulting in robust motosensory improvement, pain and tissue damage mitigation, and myelin preservation in adult rat spinal cord after injury. The scaffolded hMSC-derived neurotrophism, neurogenesis, angiogenesis, antiautoimmunity, and antiinflammation support the propriospinal network, neuromuscular junctions, and serotonergic reticulospinal reinnervation to activate the central pattern generator for restoring hindlimb locomotion. Our findings illuminate “recovery neurobiology”—i.e., the injured spinal cord may deploy polysynaptic neural circuits different from normal adulthood pathways for postinjury improvement.